Involvement of a Salmonella genomic island 1 gene in the rumen protozoan-mediated enhancement of invasion for multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium

被引:29
作者
Carlson, Steve A. [1 ]
Sharma, Vijay K. [1 ]
McCuddin, Zoe P. [1 ]
Rasmussen, Mark A. [1 ]
Franklin, Sharon K. [1 ]
机构
[1] USDA ARS, Natl Anim Dis Ctr, Preharvest Food Safety & Enter Dis Res Unit, Ames, IA 50010 USA
关键词
D O I
10.1128/IAI.00679-06
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Multiple-antibiotic-resistant Salmonella enterica serotype Typhimurium is a food-borne pathogen that may be more virulent than related strains lacking the multiresistance phenotype. Salmonella enterica serotype Typhimurium phage type DT104 is the most prevalent of these multiresistant/hypervirulent strains. Multiresistance in DT104 is conferred by an integron structure, designated Salmonella genomic island 1 (SGI1), while we recently demonstrated DT104 hyperinvasion mediated by rumen protozoa (RPz) that are normal flora of cattle. Hyperinvasion was also observed in other Salmonella strains, i.e., other S. enterica serovar Typhimurium phage types and other S. enterica serovars, like S. enterica serovar Infantis, possessing SGI1, while DT104 strains lacking SGI1 were not hyperinvasive. Herein we attempted to identify SGI1 genes involved in the RPz-mediated hyperinvasion of Salmonella strains bearing SGI1. Transposon mutagenesis, coupled with a novel reporter system, revealed the involvement of an SGI1 gene previously designated SO13. Disruption of SO13 expression led to an abrogation of hyperinvasion as assessed by tissue culture invasion assays and by bovine challenge experiments. However, hyperinvasion was not observed in non-SGI1-bearing strains of Salmonella engineered to express SO13. That is, SO13 and another SGI1 gene(s) may coordinately upregulate invasion in DT104 exposed to RPz.
引用
收藏
页码:792 / 800
页数:9
相关论文
共 28 条
[1]
Detection of multidrug-resistant Salmonella enterica serotype typhimurium DT104 based on a gene which confers cross-resistance to florfenicol and chloramphenicol [J].
Bolton, LF ;
Kelley, LC ;
Lee, MD ;
Fedorka-Cray, PJ ;
Maurer, JJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1348-1351
[2]
Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar typhimurium DT104 and its identification in phage type DT120 and serovar agona [J].
Boyd, D ;
Peters, GA ;
Cloeckaert, A ;
Boumedine, KS ;
Chaslus-Dancla, E ;
Imberechts, E ;
Mulvey, MR .
JOURNAL OF BACTERIOLOGY, 2001, 183 (19) :5725-5732
[3]
Molecular characterization of an antibiotic resistance gene cluster of Salmonella typhimurium DT104 [J].
Briggs, CE ;
Fratamico, PM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :846-849
[4]
SlyA regulates the collagenase-mediated cytopathic phenotype in multiresistant Salmonella [J].
Carlson, SA ;
McCuddin, ZP ;
Wu, MT .
MICROBIAL PATHOGENESIS, 2005, 38 (04) :181-187
[5]
Detection of multiresistant Salmonella typhimurium DT104 using multiplex and fluorogenic PCR [J].
Carlson, SA ;
Bolton, LF ;
Briggs, CE ;
Hurd, HS ;
Sharma, VK ;
Fedorka-Cray, PJ ;
Jones, BD .
MOLECULAR AND CELLULAR PROBES, 1999, 13 (03) :213-222
[6]
GROWTH OF LEGIONELLA-PNEUMOPHILA IN ACANTHAMOEBA-CASTELLANII ENHANCES INVASION [J].
CIRILLO, JD ;
FALKOW, S ;
TOMPKINS, LS .
INFECTION AND IMMUNITY, 1994, 62 (08) :3254-3261
[7]
PREFERENTIAL INTERACTION OF SALMONELLA-TYPHIMURIUM WITH MOUSE PEYERS PATCH M-CELLS [J].
CLARK, MA ;
JEPSON, MA ;
SIMMONS, NL ;
HIRST, BH .
RESEARCH IN MICROBIOLOGY, 1994, 145 (07) :543-552
[8]
THE UPTAKE OF BACTERIA AND AMINO-ACIDS BY OPHRYOSCOLEX-CAUDATUS DIPLOPLASTRON-AFFINE AND SOME OTHER RUMEN ENTODINIOMORPHID PROTOZOA [J].
COLEMAN, GS ;
REYNOLDS, DJ .
JOURNAL OF APPLIED BACTERIOLOGY, 1982, 52 (01) :135-144
[9]
Variant Salmonella genomic island 1 antibiotic resistance gene cluster in Salmonella enterica serovar Albany [J].
Doublet, B ;
Lailler, R ;
Meunier, D ;
Brisabois, A ;
Boyd, D ;
Mulvey, MR ;
Chaslus-Dancla, E ;
Cloeckaert, A .
EMERGING INFECTIOUS DISEASES, 2003, 9 (05) :585-591
[10]
Doublet B, 2004, ANTIMICROB AGENTS CH, V48, P585